QIAGEN N.V.(QGEN)— Stock Profile, AI Score & Financials
Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
QIAGEN N.V. (QGEN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores QGEN at 56.6/100 on a 32-signal composite quality model, placing it at rank #1,143 of 2,961 stocks — the top half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), QIAGEN N.V. reports quarterly revenue of $2.1B, net income of $424.9M, an operating margin of 22.3%. Top institutional holders of QGEN by reported 13-F value include WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES, PRINCIPAL FINANCIAL GROUP, based on the most recent SEC filings. QGEN trades on the NYSE exchange and files with the SEC under CIK 1015820. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate QGEN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for QIAGEN N.V. directly from SEC EDGAR.
AI Quality Score
56.6/100
AI Rank
#1,143
Revenue
$2.1B
Net Income
$424.9M
Free Cash Flow
$453.3M
Operating Margin
22.3%
QGEN key financials by period
QIAGEN N.V. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
20-F
$2.1B
$424.9M
22.3%
FY 2024
20-F
$2.0B
$83.6M
4.9%
FY 2023
20-F
$2.0B
$341.3M
20.9%
FY 2022
20-F
$2.1B
$423.2M
24.8%
FY 2021
20-F
$2.3B
$512.6M
28.0%
FY 2020
20-F
$1.9B
$359.2M
20.7%
Institutions holding QGEN
Institutional investors reporting a position in QIAGEN N.V. on SEC Form 13F.
